Company Overview of Ascletis, Inc.
Ascletis, Inc., a specialty therapeutics company, discovers and develops treatments for cancer and infectious diseases. It provides ALN-VSP, a therapeutic comprising siRNAs designed to target genes critical for the growth and development of cancer cells. The company has strategic partnerships with Alnylam Pharmaceuticals, Inc.; and Minsheng Pharma. Ascletis, Inc. was founded in 2011 and is based in Chapel Hill, North Carolina with operation sites in Hangzhou, China; and Research Triangle Park, North Carolina.
1002 Northridge Lane
Chapel Hill, NC 27514
Founded in 2011
Key Executives for Ascletis, Inc.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
December 2, 2015
September 2, 2015
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Sponsored Financial Commentaries
To contact Ascletis, Inc., please visit www.ascletis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.